tradingkey.logo
tradingkey.logo
Search

Collplant Biotechnologies Ltd

CLGN
Add to Watchlist
0.299USD
-0.001-0.30%
Close 07-31 16:00ETQuotes delayed by 15 min
3.82MMarket Cap
LossP/E TTM

CLGN Cash Flow Statement

You can access the annual and quarterly cash flow statements of Collplant Biotechnologies Ltd to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-161.27%-3.05M
15.27%-2.94M
16.56%-2.88M
37.88%-2.44M
64.13%-1.17M
-47.72%-3.46M
-150.89%-3.45M
-4.91%-3.93M
5.71%-3.25M
29.92%-2.34M
312.75%6.78M
5.34%-3.74M
-7.41%-3.45M
-38.26%-3.35M
-13.06%-3.19M
-21.32%-3.96M
-129.21%-3.21M
-51.53%-2.42M
-289.19%-2.82M
-85.44%-3.26M
525.45%11.00M
2.56%-1.60M
211.20%1.49M
0.45%-1.76M
-169.55%-2.58M
---1.64M
---1.34M
---1.77M
---959.00K
Net income from continuing operations
-113.29%-3.10M
17.30%-3.21M
19.49%-3.48M
20.50%-3.35M
65.39%-1.45M
17.30%-3.88M
1.17%-4.33M
-173.06%-4.21M
-12.92%-4.20M
-6.54%-4.69M
0.05%-4.38M
234.47%5.76M
3.76%-3.71M
-16.68%-4.40M
-42.31%-4.38M
-41.05%-4.29M
-138.13%-3.86M
-29.85%-3.77M
-537.70%-3.08M
-54.13%-3.04M
732.35%10.12M
35.43%-2.91M
122.13%703.00K
-57.93%-1.97M
28.53%-1.60M
---4.50M
---3.18M
---1.25M
---2.24M
Operating gains losses
-13.93%210.00K
-10.74%216.00K
-12.55%223.00K
-12.26%229.00K
-12.86%244.00K
-14.79%242.00K
-6.25%255.00K
-1.88%261.00K
0.00%280.00K
-3.40%284.00K
-3.20%272.00K
1.92%266.00K
16.67%280.00K
31.25%294.00K
42.64%281.00K
45.81%261.00K
38.73%240.00K
34.94%224.00K
17.96%197.00K
9.82%179.00K
5.49%173.00K
-1.78%166.00K
17.61%167.00K
24.43%163.00K
69.07%164.00K
--169.00K
--142.00K
--131.00K
--97.00K
Other non-cash items
-266.67%-10.00K
84.75%-9.00K
100.00%0.00
-163.11%-77.00K
-95.20%6.00K
68.78%-59.00K
-140.71%-46.00K
-29.48%122.00K
-55.67%125.00K
-107.69%-189.00K
503.57%113.00K
-65.33%173.00K
--282.00K
-5.81%-91.00K
-300.00%-28.00K
302.42%499.00K
----
-148.31%-86.00K
-33.33%14.00K
143.14%124.00K
-101.03%-195.00K
1086.67%178.00K
-68.66%21.00K
-41.38%51.00K
-164.24%-97.00K
--15.00K
--67.00K
--87.00K
--151.00K
Change in working capital
4.32%-332.00K
153.85%98.00K
-34.42%101.00K
168.02%402.00K
-240.49%-347.00K
-110.92%-182.00K
-98.50%154.00K
94.25%-591.00K
130.46%247.00K
303.63%1.67M
3826.05%10.25M
-956.83%-10.28M
-1878.05%-811.00K
-58.37%413.00K
188.47%261.00K
-5.76%-973.00K
-109.34%-41.00K
106.24%992.00K
-237.21%-295.00K
-110.05%-920.00K
131.77%439.00K
37.82%481.00K
-25.86%215.00K
1.79%-438.00K
-2659.26%-1.38M
--349.00K
--290.00K
---446.00K
--54.00K
-Change in receivables
-106.29%-9.00K
119.74%30.00K
-64.40%110.00K
120.49%76.00K
495.83%143.00K
-246.15%-152.00K
-97.03%309.00K
96.36%-371.00K
113.41%24.00K
292.59%104.00K
9824.76%10.42M
-2896.18%-10.19M
-141.53%-179.00K
-129.35%-54.00K
-72.22%105.00K
58.28%-340.00K
-31.37%431.00K
-50.54%184.00K
202.16%378.00K
-77.17%-815.00K
339.69%628.00K
131.06%372.00K
-193.67%-370.00K
-362.86%-460.00K
-1.16%-262.00K
--161.00K
--395.00K
--175.00K
---259.00K
-Change in inventory
55.41%-103.00K
-313.33%-32.00K
193.33%14.00K
-42.31%120.00K
-420.83%-231.00K
-98.25%15.00K
-131.25%-15.00K
9.47%208.00K
120.87%72.00K
423.02%856.00K
-78.95%48.00K
313.48%190.00K
-85.48%-345.00K
-468.06%-265.00K
207.04%228.00K
-126.57%-89.00K
-1330.77%-186.00K
124.41%72.00K
10.13%-213.00K
-11.14%335.00K
94.06%-13.00K
-426.79%-295.00K
-288.10%-237.00K
528.41%377.00K
-291.07%-219.00K
---56.00K
--126.00K
---88.00K
---56.00K
-Change in payables and accrued expense
-144.79%-235.00K
-31.25%22.00K
-107.69%-108.00K
134.52%136.00K
-257.38%-96.00K
-90.24%32.00K
49.02%-52.00K
-347.73%-394.00K
-7.58%61.00K
-31.09%328.00K
35.03%-102.00K
-414.29%-88.00K
119.82%66.00K
0.85%476.00K
74.96%-157.00K
135.00%28.00K
-45.41%-333.00K
59.46%472.00K
-180.28%-627.00K
-433.33%-80.00K
36.57%-229.00K
-25.44%296.00K
453.90%781.00K
-47.83%24.00K
-902.22%-361.00K
--397.00K
--141.00K
--46.00K
--45.00K
-Change in other current assets
----
-371.04%-496.00K
-1.16%171.00K
1.27%160.00K
20.44%165.00K
--183.00K
--173.00K
--158.00K
--137.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-Change in other current liabilities
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
100.00%0.00
-100.00%0.00
--0.00
100.00%0.00
25.58%-32.00K
129.09%32.00K
-100.00%0.00
57.95%-164.00K
83.14%-43.00K
50.00%-110.00K
105.31%20.00K
-36.84%-390.00K
-102.38%-255.00K
---220.00K
---377.00K
---285.00K
---126.00K
Cash from non-recurring investing activities
Cash from operating activities
-161.27%-3.05M
15.27%-2.94M
16.56%-2.88M
37.88%-2.44M
64.13%-1.17M
-47.72%-3.46M
-150.89%-3.45M
-4.91%-3.93M
5.71%-3.25M
29.92%-2.34M
312.75%6.78M
5.34%-3.74M
-7.41%-3.45M
-38.26%-3.35M
-13.06%-3.19M
-21.32%-3.96M
-129.21%-3.21M
-51.53%-2.42M
-289.19%-2.82M
-85.44%-3.26M
525.45%11.00M
2.56%-1.60M
211.20%1.49M
0.45%-1.76M
-169.55%-2.58M
---1.64M
---1.34M
---1.77M
---959.00K
Investing cash flow
Net cash from continuing investing activities
-25.00%6.00K
-74.14%15.00K
-99.29%1.00K
-98.51%3.00K
-90.24%8.00K
-63.98%58.00K
-42.39%140.00K
-40.06%202.00K
-43.45%82.00K
-47.04%161.00K
-24.53%243.00K
-13.14%337.00K
-51.99%145.00K
-35.86%304.00K
-49.29%322.00K
44.78%388.00K
68.72%302.00K
236.17%474.00K
381.06%635.00K
66.46%268.00K
110.59%179.00K
-54.07%141.00K
40.43%132.00K
-53.87%161.00K
-88.05%85.00K
--307.00K
--94.00K
--349.00K
--711.00K
Capital expenditures
-33.33%6.00K
-74.58%15.00K
-99.29%1.00K
-98.51%3.00K
-89.02%9.00K
-74.24%59.00K
-42.39%140.00K
-40.06%202.00K
-43.45%82.00K
-24.67%229.00K
-24.53%243.00K
-13.14%337.00K
-51.99%145.00K
-40.04%304.00K
-49.29%322.00K
44.78%388.00K
68.72%302.00K
259.57%507.00K
381.06%635.00K
66.46%268.00K
110.59%179.00K
-58.16%141.00K
40.43%132.00K
-53.87%161.00K
-88.05%85.00K
--337.00K
--94.00K
--349.00K
--711.00K
Net cash flow from disposal of fixed assets
-25.00%6.00K
-74.14%15.00K
-99.29%1.00K
-98.51%3.00K
-90.24%8.00K
-63.98%58.00K
-42.39%140.00K
-40.06%202.00K
-43.45%82.00K
-43.90%161.00K
-21.36%243.00K
-11.78%337.00K
-51.01%145.00K
-32.47%287.00K
-48.93%309.00K
57.85%382.00K
140.65%296.00K
304.76%425.00K
603.49%605.00K
50.31%242.00K
44.71%123.00K
-65.80%105.00K
-8.51%86.00K
-53.87%161.00K
-88.05%85.00K
--307.00K
--94.00K
--349.00K
--711.00K
Net cash flow from intangible asset transactions
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-65.31%17.00K
-56.67%13.00K
-76.92%6.00K
-89.29%6.00K
36.11%49.00K
-34.78%30.00K
--26.00K
--56.00K
--36.00K
--46.00K
----
----
----
----
----
----
Net cash flow from investment products
----
----
--0.00
----
----
-100.00%0.00
--0.00
3.39%-57.00K
----
--59.00K
--0.00
99.70%-59.00K
----
100.00%0.00
-100.00%0.00
33.33%-20.00M
--0.00
---10.00M
--10.00M
---30.00M
----
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
----
--0.00
----
----
----
----
----
----
----
---270.00K
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--20.05M
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
25.00%-6.00K
74.14%-15.00K
99.29%-1.00K
98.84%-3.00K
90.24%-8.00K
84.41%-58.00K
42.39%-140.00K
34.60%-259.00K
43.45%-82.00K
-22.37%-372.00K
24.53%-243.00K
-17.51%-396.00K
---145.00K
97.10%-304.00K
-103.44%-322.00K
98.89%-337.00K
----
-7328.37%-10.47M
7194.70%9.37M
-18700.00%-30.27M
-110.59%-179.00K
54.07%-141.00K
-40.43%-132.00K
53.87%-161.00K
88.05%-85.00K
---307.00K
---94.00K
---349.00K
---711.00K
Financing cash flow
Cash flow from continuous financing activities
--1.72M
--0.00
--0.00
--3.10M
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-98.88%9.00K
-100.00%0.00
--216.00K
--89.00K
-45.52%803.00K
181.69%400.00K
-100.00%0.00
-100.00%0.00
-95.85%1.47M
2466.67%142.00K
10818.75%1.75M
2614.81%1.36M
687.60%35.51M
0.00%-6.00K
-99.71%16.00K
-1900.00%-54.00K
21571.43%4.51M
---6.00K
--5.43M
--3.00K
---21.00K
Net cash flow from debt Issuance/repayment
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
0.00%-6.00K
0.00%-6.00K
-50.00%-6.00K
-50.00%-6.00K
---6.00K
---6.00K
---4.00K
---4.00K
Net cash flow from common stock issuance/repurchase
--1.72M
--0.00
--0.00
--3.10M
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
100.00%0.00
635.80%32.74M
--0.00
-100.00%0.00
---50.00K
--4.45M
--0.00
--5.44M
--0.00
--0.00
Proceeds from stock option exercised by employees
----
----
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-98.88%9.00K
-100.00%0.00
--216.00K
--89.00K
-45.52%803.00K
181.69%400.00K
-100.00%0.00
-100.00%0.00
-46.79%1.47M
--142.00K
7840.91%1.75M
67800.00%1.36M
4161.54%2.77M
--0.00
--22.00K
-71.43%2.00K
--65.00K
--0.00
--0.00
--7.00K
--0.00
Net cash flow from other financing activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---17.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--1.72M
--0.00
--0.00
--3.10M
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-98.88%9.00K
-100.00%0.00
--216.00K
--89.00K
-45.52%803.00K
181.69%400.00K
-100.00%0.00
-100.00%0.00
-95.85%1.47M
2466.67%142.00K
10818.75%1.75M
2614.81%1.36M
687.60%35.51M
0.00%-6.00K
-99.71%16.00K
-1900.00%-54.00K
21571.43%4.51M
---6.00K
--5.43M
--3.00K
---21.00K
Net cash flow
Beginning cash balance
-53.05%5.59M
-44.40%8.55M
-39.57%11.43M
-53.78%10.73M
-55.35%11.91M
-47.35%15.37M
-15.41%18.92M
-12.62%23.23M
-10.68%26.67M
-11.60%29.19M
-38.73%22.37M
-35.63%26.58M
123.30%29.86M
27.14%33.02M
106.52%36.50M
-17.29%41.29M
279.30%13.37M
397.85%25.97M
358.97%17.68M
762.58%49.93M
-11.21%3.53M
-11.86%5.22M
101.20%3.85M
43.80%5.79M
-29.88%3.97M
--5.92M
--1.91M
--4.03M
--5.66M
Current period cash flow changes
-13.20%-1.33M
14.62%-2.96M
18.65%-2.89M
116.24%699.00K
65.96%-1.17M
-37.49%-3.46M
-153.65%-3.55M
-2.18%-4.30M
-12.20%-3.45M
20.29%-2.52M
290.14%6.62M
12.06%-4.21M
-111.01%-3.07M
74.93%-3.16M
-141.93%-3.48M
85.14%-4.79M
-39.83%27.92M
-645.06%-12.60M
507.47%8.30M
-1565.00%-32.25M
2453.66%46.40M
13.19%-1.69M
-65.89%1.37M
8.24%-1.94M
210.93%1.82M
---1.95M
--4.00M
---2.11M
---1.64M
Effect of exchange rate changes
600.00%7.00K
-110.00%-6.00K
-123.08%-9.00K
133.90%40.00K
100.81%1.00K
-69.85%60.00K
129.10%39.00K
27.16%-118.00K
56.38%-123.00K
118.68%199.00K
-578.57%-134.00K
67.54%-162.00K
-223.68%-282.00K
-40.52%91.00K
833.33%28.00K
-516.05%-499.00K
235.29%228.00K
188.68%153.00K
142.86%3.00K
-325.00%-81.00K
409.09%68.00K
1225.00%53.00K
-275.00%-7.00K
3500.00%36.00K
-141.51%-22.00K
--4.00K
--4.00K
--1.00K
--53.00K
Ending cash balance
-60.30%4.26M
-53.05%5.59M
-44.40%8.55M
-39.57%11.43M
-53.78%10.73M
-55.35%11.91M
-46.96%15.37M
-15.41%18.92M
-13.31%23.23M
-10.68%26.67M
-12.24%28.98M
-38.73%22.37M
-35.12%26.79M
123.30%29.86M
27.14%33.02M
106.52%36.50M
-17.29%41.29M
279.30%13.37M
397.85%25.97M
358.97%17.68M
762.58%49.93M
-11.21%3.53M
-11.86%5.22M
101.20%3.85M
43.80%5.79M
--3.97M
--5.92M
--1.91M
--4.03M
Free cash flow
-159.78%-3.06M
16.26%-2.95M
19.79%-2.88M
40.85%-2.44M
64.74%-1.18M
-36.87%-3.52M
-154.92%-3.59M
-1.20%-4.13M
7.23%-3.33M
29.48%-2.57M
286.28%6.53M
6.03%-4.08M
-2.31%-3.59M
-24.70%-3.65M
-1.59%-3.51M
-23.10%-4.34M
-132.48%-3.51M
-68.41%-2.93M
-354.38%-3.45M
-83.85%-3.53M
505.21%10.82M
12.04%-1.74M
194.70%1.36M
9.27%-1.92M
-59.88%-2.67M
---1.98M
---1.43M
---2.12M
---1.67M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Collplant Biotechnologies Ltd Generate?

Collplant Biotechnologies Ltd generated -9.42M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Collplant Biotechnologies Ltd's Operating Cash Flow Change Year Over Year?

Collplant Biotechnologies Ltd's operating cash flow increased by 33.17% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Collplant Biotechnologies Ltd Spend on Capital Expenditures?

Collplant Biotechnologies Ltd spent 28.00K on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Collplant Biotechnologies Ltd's Financing Cash Flow Changed?

Collplant Biotechnologies Ltd used 3.10M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CLGN?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Collplant Biotechnologies Ltd’s free cash flow in the latest quarter?

Free cash flow was -9.45M reflecting a 35.19% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.